WDNA WisdomTree BioRevolution Fund
This fund primarily aims to meet its investment goals by employing a representative sampling method. This means it selects a portion of the securities from its benchmark index, ensuring that this smaller selection closely reflects the broader index's risk profile, expected returns, and other key characteristics. The benchmark index itself is crafted to invest in global, exchange-listed companies that are poised for significant transformation through breakthroughs in genetic research and biotechnology. It's important to note that this fund is categorized as non-diversified.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| WDNA | -1.1% | +5.6% | +32.8% | +36.2% | +17.0% | -2.1% |
| Sector Equity average (81 funds) | -1.2% | -4.5% | +13.3% | +15.0% | +17.1% | +6.1% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: −$10K net.
Holdings · as of Nov 9, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | TEM Tempus Ai Inc | 3.74% |
| 2 | LLY Eli Lilly & Co | 3.64% |
| 3 | MRNA Moderna Inc | 3.38% |
| 4 | TWST Twist Bioscience Corp | 3.00% |
| 5 | IMNM Immunome Inc | 2.92% |
| 6 | TMO Thermo Fisher Scientific Inc | 2.56% |
| 7 | NTRA Natera Inc | 2.38% |
| 8 | STOK Stoke Therapeutics Inc | 2.33% |
| 9 | UTHR United Therapeutics Corp | 2.14% |
| 10 | TXG 10X Genomics Inc-Class A | 1.92% |
| 11 | VRTX Vertex Pharmaceuticals Inc | 1.90% |
| 12 | AMGN Amgen Inc | 1.81% |
| 13 | GILD Gilead Sciences Inc | 1.81% |
| 14 | CGON Cg Oncology Inc | 1.78% |
| 15 | ROIV Roivant Sciences Ltd | 1.75% |
| 16 | RVMD Revolution Medicines Inc | 1.68% |
| 17 | AZN.L Astrazeneca Plc | 1.65% |
| 18 | BAYN.DE Bayer AG | 1.59% |
| 19 | DAR Darling Ingredients Inc | 1.55% |
| 20 | CRSP Crispr Therapeutics Ag | 1.53% |
| 21 | PFE Pfizer Inc | 1.50% |
| 22 | VYLR Vylor Inc | 1.49% |
| 23 | BEAM Beam Therapeutics Inc | 1.47% |
| 24 | XNCR Xencor Inc | 1.45% |
| 25 | KRYS Krystal Biotech Inc | 1.42% |
| 26 | DYN Dyne Therapeutics Inc | 1.37% |
| 27 | NZYM-B.CO Novozymes A/S | 1.37% |
| 28 | ORKA Oruka Therapeutics Inc | 1.33% |
| 29 | PRME Prime Medicine Inc | 1.30% |
| 30 | NOVN.SW Novartis AG | 1.26% |
| 31 | BHVN Biohaven Ltd | 1.21% |
| 32 | BBIO Bridgebio Pharma Inc | 1.20% |
| 33 | EXEL Exelixis Inc | 1.19% |
| 34 | AGIO Agios Pharmaceuticals Inc | 1.12% |
| 35 | ABSI ABSCI Corp | 1.10% |
| 36 | VIR Vir Biotechnology Inc | 1.10% |
| 37 | QURE Uniqure NV | 1.06% |
| 38 | PRAX Praxis Precision Medicines I | 1.05% |
| 39 | GPCR Structure Therapeutics Inc | 1.05% |
| 40 | PTGX Protagonist Therapeutics Inc | 1.01% |
| 41 | WVE Wave Life Sciences Inc | 0.97% |
| 42 | ARWR Arrowhead Pharmaceuticals Inc | 0.96% |
| 43 | FDMT 4D Molecular Therapeutics In | 0.96% |
| 44 | ARGX Argenx Se - Adr | 0.96% |
| 45 | RCKT Rocket Pharmaceuticals Inc | 0.95% |
| 46 | NTLA Intellia Therapeutics Inc | 0.95% |
| 47 | CAI Caris Life Sciences Inc | 0.91% |
| 48 | GRAL Grail Inc | 0.91% |
| 49 | IDYA Ideaya Biosciences Inc | 0.87% |
| 50 | BIIB Biogen Idec Inc | 0.86% |
| 51 | IONS Isis Pharmaceuticals Inc | 0.85% |
| 52 | RGEN Repligen Corp | 0.85% |
| 53 | DHR Danaher Corp | 0.83% |
| 54 | HALO Halozyme Therapeutics Inc | 0.78% |
| 55 | BNTX Biontech Se-ADR | 0.77% |
| 56 | ARCT Arcturus Therapeutics Hlgs | 0.76% |
| 57 | GMAB Genmab A/S -Sp ADR | 0.74% |
| 58 | CLDX Celldex Therapeutics Inc | 0.73% |
| 59 | ALNY Alnylam Pharmaceuticals Inc | 0.73% |
| 60 | MRK Merck & Co Inc/NJ | 0.72% |
| 61 | REGN Regeneron Pharmaceuticals Inc | 0.71% |
| 62 | NRIX Nurix Therapeutics Inc | 0.69% |
| 63 | EDIT Editas Medicine Inc | 0.66% |
| 64 | ONT.L Oxford Nanopore Technologies | 0.66% |
| 65 | IOVA Iovance Biotherapeutics Inc | 0.63% |
| 66 | SYENS.BR Syensqo Sa | 0.63% |
| 67 | ILMN Illumina Inc | 0.59% |
| 68 | VKTX Viking Therapeutics Inc | 0.59% |
| 69 | CGEM Cullinan Therapeutics Inc | 0.59% |
| 70 | INSM Insmed Inc | 0.57% |
| 71 | QGEN QIAGEN N.V. | 0.56% |
| 72 | NUF.AX Nufarm Ltd/Australia | 0.55% |
| 73 | GNS.L Genus Plc | 0.54% |
| 74 | VCYT Veracyte Inc | 0.54% |
| 75 | ZTS Zoetis Inc | 0.53% |
| 76 | VBK.DE Verbio AG | 0.51% |
| 77 | BMRN BioMarin Pharmaceutical Inc | 0.51% |
| 78 | RGNX Regenxbio Inc | 0.50% |
| 79 | NPCE Neuropace Inc | 0.50% |
| 80 | RARE Ultragenyx Pharmaceutical Inc | 0.49% |
| 81 | GPRE Green Plains Inc | 0.46% |
| 82 | GERN Geron Corp | 0.40% |
| 83 | ALLO Allogene Therapeutics Inc | 0.37% |
| 84 | WDNA DREYFUS TRSY OBLIG CASH MGMT CL INS | 0.02% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 26, 2025 | $0.7705 |
| Dec 26, 2024 | $0.1071 |
| Dec 22, 2023 | $0.1350 |
| Dec 23, 2022 | $0.0653 |
| Dec 27, 2021 | $0.0246 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in WDNA in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error